cbdMD, Inc. - YCBD Company profit before taxes, interest and amortization
cbdMD, Inc. (YCBD) creates cannabidiol products for humans and animals, targeting the US wellness market. The EBITDA result confirms this model, where the 0.00 indicator expresses the state of the metric. Growth is based on raw material purity and product line expansion. High confidence in brand safety has established the company as an industry benchmark.
cbdMD (YCBD) - metric breakdowns and financial figures
- market value and analyst target forecast:
- issuer market value details:
- issuer book value statistics:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio cbdMD, Inc.|YCBD - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio cbdMD Inc.|YCBD - Company Aggregate Debts|Debt to Book Capitalization Ratio cbdMD|YCBD - Company Long-Term Debts|Company Short-Term Indebtedness cbdMD|Quick Liquidity Indicator cbdmd.com
- earnings and market ratios statistics:
YCBD - Net Profit|Net Profit Forecast cbdMD, Inc.|YCBD - Price to Earnings Ratio|Future Price to Earnings Multiple cbdMD Inc.|YCBD - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio cbdMD|YCBD - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months cbdMD|YCBD - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months cbdmd.com|YCBD - Net earnings per share growth this year|Consensus forecast of earnings per share growth for next year cbdMD, Inc.
Summary company analytics:cbdMD, Inc. (YCBD)
The implementation of robotic filling and packaging lines for CBD products minimizes manual labor costs, directly impacting cash flow dynamics for cbdMD, Inc. (YCBD). By analyzing the earnings before interest, taxes, depreciation, and amortization (EBITDA), an investor assesses the business's actual ability to generate cash before accounting for debt and fiscal obligations, which allows them to filter out speculative noise and confirm the fundamental stability of the market capitalization of cbdMD, Inc. (YCBD).
Who cbdMD, Inc. competes with
Haleon Corp (HLN) - Profit before interest, taxes and amortization|KVUE: Operating profit before deduction of amortization|veronapharma.com - Company profit before taxes, interest and amortization|MENS: Operating profit EBITDA|Ligand Pharmaceuticals Incorporated - Income before deduction of interest, taxes and amortization|AMRX (Amneal Pharmaceuticals Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization Perrigo Corp PRGO|Profit before payment of interest, taxes and amortization Alvotech (ALVO)|LQDA (liquidia.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA GLPG (Galapagos)|ANIP - Operating profit before deduction of amortization|MannKind Corp. - Operating profit EBITDA|AMPH: Profit before payment of interest, taxes and amortization|PCRX: Operating profit EBITDA|Operating profit before amortization SPRY|Profit before payment of interest, taxes and amortization Theravance Biopharma, Inc.|Operating profit before deduction of amortization Aquestive Therapeutics Inc (AQST)|Operating profit EBITDA SCPH|tectonictx.com - Operating profit before amortization|Tonix Pharmaceuticals - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SXTC|Eupraxia Pharma - Operating profit EBITDA|Operating income before deduction of amortization BioHarvest Sciences, Inc. BHST|Invizyne Technologies, Inc. (EXOZ) - Profit before payment of interest, taxes and amortization|Operating profit before amortization ORMP|ENTX (Entera Bio Ltd) - Operating profit EBITDA|Operating profit before deduction of amortization ipatherapeutics.com (HYFT)|Operating profit before deduction of amortization ABVC (ABVC BioPharma, Inc.)|Operating income before deduction of amortization Cumberland Pharmaceuticals Inc|Quantum BioPharma Limited - Operating profit before deduction of amortization|FibroGen Corporation (FGEN) - Profit before interest, taxes and amortization|Telomir Pharmaceuticals - Operating profit EBITDA|Rani Therapeutics (RANI) - Operating profit before deduction of amortization|SNYR: Operating profit EBITDA|RLYB (Rallybio) - Profit before payment of interest, taxes and amortization|LEXX (Lexaria Bioscience Corp) - Operating profit EBITDA|Operating profit before amortization PULM (Pulmatrix Corporation)|Profit before payment of interest, taxes and amortization Pheton Holdings Ltd (PTHL)|APM: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA LYRA (Lyra Therapeutics)|Income before deduction of interest, taxes and amortization IBO|TNF Pharma - Operating profit EBITDA|PRFX - Operating profit EBITDA|altamiratherapeutics.com (CYTO) - Profit before payment of interest, taxes and amortization|lipella.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization OptiNose|Operating profit before deduction of amortization Pieris Pharmaceuticals Inc (PIRS)|Operating profit EBITDA PROC|Operating profit EBITDA Petros Pharma (PTPI)|Qilian International - Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization SLRN|TFFP - Profit before payment of interest, taxes and amortization
